- Supported exchanges /
- F /
- CBO.F
IMUNON INC. DL-01 (CBO F) stock market data APIs
Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
IMUNON INC. DL-01 Financial Data Overview
| 0.84 | |
| 0.84 | |
| - | |
| 0.84 | |
| 0.84 | |
| 0.438-3.7 | |
| 12 570 K | |
| 14 401 K | |
| 125 K | |
| 2.125 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
IMUNON INC. DL-01 Fundamental Data is available in our Financial Data APIs
- Net Revenue 125 K
- EBITDA -19 618 188
- Earnings Per Share -1.75
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get IMUNON INC. DL-01 Earnings via APIs
- Latest Release 2024-11-07
- EPS/Forecast NaN
Get IMUNON INC. DL-01 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
